{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T23:36:19Z","timestamp":1772494579933,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"a faculty research grant of Yonsei University College of Medicine, Seoul, Republic of Korea","award":["6-2023-0155"],"award-info":[{"award-number":["6-2023-0155"]}]},{"name":"CELLTRION PHARM, Inc. Chungcheongbuk-do, Republic of Korea","award":["NCR 2019-6"],"award-info":[{"award-number":["NCR 2019-6"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study investigated the clinical implications of peripheral eosinophil count at diagnosis in estimating cross-sectional antineutrophil cytoplasmic antibody-associated vasculitis (AAV) activity and predicting all-cause mortality during follow-up in patients newly diagnosed with microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 224 immunosuppressive drug-na\u00efve patients with peripheral eosinophil count at diagnosis\u2009&lt;\u20091,000\/mm<jats:sup>3<\/jats:sup>. The Birmingham Vasculitis Activity Score (BVAS), the Five-Factor Score (FFS), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) at diagnosis were assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median age of the 224 patients (152 MPA and 72 GPA) was 62.0\u00a0years; 35.3% of them were men. At diagnosis, peripheral eosinophil count was significantly correlated with BVAS (<jats:italic>P<\/jats:italic>\u2009=\u20090.001), FFS (<jats:italic>P<\/jats:italic>\u2009=\u20090.046), ESR (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and CRP (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Deceased patients had a significantly higher median peripheral eosinophil count at diagnosis than surviving patients (310.0\/mm<jats:sup>3<\/jats:sup> vs. 170.0\/mm<jats:sup>3<\/jats:sup>, <jats:italic>P<\/jats:italic>\u2009=\u20090.004). In addition, patients with MPA and those with cardiovascular and renal manifestations at diagnosis exhibited significantly higher peripheral eosinophil counts than those without. When the optimal cut-off of peripheral eosinophil count at diagnosis for all-cause mortality during follow-up was set at 175.0\/mm<jats:sup>3<\/jats:sup>, Patients with peripheral eosinophil count at diagnosis\u2009\u2265\u2009175.0\/mm<jats:sup>3<\/jats:sup> exhibited a significantly lower cumulative patients\u2019 survival rate than those with peripheral eosinophil count at diagnosis\u2009&lt;\u2009175.0\/mm<jats:sup>3<\/jats:sup> (<jats:italic>P<\/jats:italic>\u2009=\u20090.008).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study was the first to demonstrate that peripheral eosinophil count at diagnosis could estimate cross-sectional AAV activity at diagnosis and contribute to predicting all-cause mortality during follow-up in MPA and GPA patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03233-1","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T08:02:16Z","timestamp":1702627336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jang Woo","family":"Ha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason Jungsik","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"3233_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"3233_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222\u20137.","journal-title":"Ann Rheum Dis"},{"key":"3233_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","volume":"6","author":"AR Kitching","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, et al. ANCA-associated vasculitis Nat Rev Dis Primers. 2020;6:71.","journal-title":"ANCA-associated vasculitis Nat Rev Dis Primers"},{"key":"3233_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3349\/ymj.2019.60.8.705","volume":"60","author":"CB Choi","year":"2019","unstructured":"Choi CB, Park YB, Lee SW. Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients. Yonsei Med J. 2019;60:705\u201312.","journal-title":"Yonsei Med J"},{"key":"3233_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","volume":"81","author":"R Suppiah","year":"2022","unstructured":"Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis. 2022;81:321\u20136.","journal-title":"Ann Rheum Dis"},{"key":"3233_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","volume":"81","author":"JC Robson","year":"2022","unstructured":"Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, et al. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81:315\u201320.","journal-title":"Ann Rheum Dis"},{"key":"3233_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3349\/ymj.2022.0435","volume":"64","author":"JY Pyo","year":"2023","unstructured":"Pyo JY, Lee LE, Park YB, Lee SW. Comparison of the 2022 ACR\/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria. Yonsei Med J. 2023;64:11\u20137.","journal-title":"Yonsei Med J"},{"key":"3233_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00001648-200005000-00006","volume":"11","author":"JJ Hospers","year":"2000","unstructured":"Hospers JJ, Schouten JP, Weiss ST, Postma DS, Rijcken B. Eosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sample. Epidemiology. 2000;11:261\u20138.","journal-title":"Epidemiology"},{"key":"3233_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MEJ.0b013e32834c67eb","volume":"19","author":"MA Cikrikcioglu","year":"2012","unstructured":"Cikrikcioglu MA, Soysal P, Dikerdem D, Cakirca M, Kazancioglu R, Yolbas S, et al. Absolute blood eosinophil count and 1-year mortality risk following hospitalization with acute heart failure. Eur J Emerg Med. 2012;19:257\u201363.","journal-title":"Eur J Emerg Med"},{"key":"3233_CR10","doi-asserted-by":"publisher","first-page":"1051732","DOI":"10.3389\/fneur.2023.1051732","volume":"14","author":"H Gonzalez Gomez","year":"2023","unstructured":"Gonzalez Gomez H, Savarraj JPJ, Paz AS, Ren X, Chen H, McCullough LD, et al. Peripheral eosinophil trends and clinical outcomes after non-traumatic subarachnoid hemorrhage. Front Neurol. 2023;14:1051732.","journal-title":"Front Neurol"},{"key":"3233_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40560-015-0093-4","volume":"3","author":"EJ Escobar-Valdivia","year":"2015","unstructured":"Escobar-Valdivia EJ, Gonz\u00e1lez-Aguirre JE, Carrillo-Cisneros ER, Guerra-Leza KC, Mercado-Longor\u00eda R. Eosinophil count at intensive care unit admission was not predictor of hospital mortality: results of a case control study. J Intensive Care. 2015;3:27.","journal-title":"J Intensive Care"},{"key":"3233_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1046\/j.1365-2249.2001.125002332.x","volume":"125","author":"CE Balding","year":"2001","unstructured":"Balding CE, Howie AJ, Drake-Lee AB, Savage CO. Th2 dominance in nasal mucosa in patients with Wegener\u2019s granulomatosis. Clin Exp Immunol. 2001;125:332\u20139.","journal-title":"Clin Exp Immunol"},{"key":"3233_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/09273940591004250","volume":"13","author":"P Choopong","year":"2005","unstructured":"Choopong P, Khan N, Sangwan VS, Zafirakis P, Rallatos CL, Rojas B, et al. Eosinophil activation in Wegener\u2019s granulomatosis: a harbinger of disease progression? Ocul Immunol Inflamm. 2005;13:439\u201345.","journal-title":"Ocul Immunol Inflamm"},{"key":"3233_CR14","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68:1827\u201332.","journal-title":"Ann Rheum Dis"},{"key":"3233_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin PL, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90:19\u201327.","journal-title":"Medicine (Baltimore)"},{"key":"3233_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jama.2013.13805","volume":"310","author":"CJ Murray","year":"2013","unstructured":"Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, et al. The state of US health, 1990\u20132010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591\u2013608.","journal-title":"JAMA"},{"key":"3233_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","volume":"81","author":"PC Grayson","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. Ann Rheum Dis. 2022;81:309\u201314.","journal-title":"Ann Rheum Dis"},{"key":"3233_CR18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2021;73:1366\u201383.","journal-title":"Arthritis Rheumatol"},{"key":"3233_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41927-019-0059-6","volume":"3","author":"T Hellmark","year":"2019","unstructured":"Hellmark T, Ohlsson S, Pettersson \u00c5, Hansson M, Johansson \u00c5CM. Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis. BMC Rheumatol. 2019;3:9.","journal-title":"BMC Rheumatol"},{"key":"3233_CR20","doi-asserted-by":"publisher","first-page":"e28305","DOI":"10.1097\/MD.0000000000028305","volume":"100","author":"MA Dagostin","year":"2021","unstructured":"Dagostin MA, Nunes SLO, Shinjo SK, Pereira RMR. Mortality predictors in ANCA-associated vasculitis: Experience of a Brazilian monocentric cohort of a rheumatology center. Medicine (Baltimore). 2021;100:e28305.","journal-title":"Medicine (Baltimore)"},{"key":"3233_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-016-0619-3","volume":"18","author":"LE Vega","year":"2016","unstructured":"Vega LE, Espinoza LR. Predictors of Poor Outcome in ANCA-Associated Vasculitis (AAV). Curr Rheumatol Rep. 2016;18:70.","journal-title":"Curr Rheumatol Rep"},{"key":"3233_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24237","volume":"36","author":"PG Park","year":"2022","unstructured":"Park PG, Song JJ, Park YB, Lee SW. Clinical application of low erythrocyte sedimentation rate\/high C-reactive protein to antineutrophil cytoplasmic antibody-associated vasculitis. J Clin Lab Anal. 2022;36: e24237.","journal-title":"J Clin Lab Anal"},{"key":"3233_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3349\/ymj.2019.60.1.10","volume":"60","author":"CB Choi","year":"2019","unstructured":"Choi CB, Park YB, Lee SW. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review. Yonsei Med J. 2019;60:10\u201321.","journal-title":"Yonsei Med J"},{"key":"3233_CR24","first-page":"L117","volume":"268","author":"RA Erger","year":"1995","unstructured":"Erger RA, Casale TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol. 1995;268:L117\u201322.","journal-title":"Am J Physiol"},{"key":"3233_CR25","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1084\/jem.181.6.2119","volume":"181","author":"PJ Daffern","year":"1995","unstructured":"Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med. 1995;181:2119\u201327.","journal-title":"J Exp Med"},{"key":"3233_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1165\/ajrcmb\/8.4.349","volume":"8","author":"MB Resnick","year":"1993","unstructured":"Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol. 1993;8:349\u201355.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3233_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/jcm7120529","volume":"7","author":"P Gauckler","year":"2018","unstructured":"Gauckler P, Shin JI, Mayer G, Kronbichler A. Eosinophilia and Kidney Disease: More than Just an Incidental Finding? J Clin Med. 2018;7:529.","journal-title":"J Clin Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03233-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T08:08:53Z","timestamp":1702627733000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03233-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3233"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03233-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Institutional Review Board (IRB) of Severance Hospital (Seoul, Korea, IRB No. 4\u20132020-1071), and was conducted according to the Declaration of Helsinki. Given the retrospective design of the study and the use of anonymised patient data, the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to particpate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not commissioned; externally peer reviewed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Provenance and peer review"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}